Compare CWH & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWH | TYRA |
|---|---|---|
| Founded | 1966 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2016 | 2021 |
| Metric | CWH | TYRA |
|---|---|---|
| Price | $11.53 | $29.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $16.71 | ★ $40.75 |
| AVG Volume (30 Days) | ★ 2.5M | 689.8K |
| Earning Date | 02-24-2026 | 03-26-2026 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,400,054,000.00 | N/A |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $3.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.58 | N/A |
| 52 Week Low | $9.49 | $6.42 |
| 52 Week High | $24.37 | $32.44 |
| Indicator | CWH | TYRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 47.68 |
| Support Level | $12.88 | $29.47 |
| Resistance Level | $14.08 | $31.39 |
| Average True Range (ATR) | 0.81 | 2.56 |
| MACD | -0.27 | -0.43 |
| Stochastic Oscillator | 2.50 | 43.91 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.